Selective α7 nicotinic receptor stimulation normalizes chronic cocaine- induced loss of hippocampal sensory inhibition in C3H mice

Biological Psychiatry

Volumn 46, Issue 10, 1999, Pages 1443-1450

  Stevens, Karen E ^a   Kem, William R ^a,b   Freedman, Robert ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Acetylcholine; Anabaseine; Cocaine abuse; Hippocampus; Inbred mouse strains; Nicotinic receptors

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ALPHA ADRENERGIC RECEPTOR; ALPHA BUNGAROTOXIN; COCAINE; MECAMYLAMINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; COCAINE DEPENDENCE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED AUDITORY RESPONSE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TACHYPHYLAXIS;

ANIMALS; AUDITORY PERCEPTION; CHRONIC DISEASE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C3H; NEURAL INHIBITION; NEURONS, AFFERENT; NICOTINE; NICOTINIC AGONISTS; PERCEPTUAL DISORDERS; RECEPTORS, CHOLINERGIC; RECEPTORS, NICOTINIC;

EID: 0032753990     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00200-0     Document Type: Article

References (64)

1. Adams C.E., Freedman R. Nicotinic antagonist α-bungarotoxin binding to rat hippocampal neurons containing nitric oxide synthase. Brain Res. 776:1997;111-116.
2. Adams C.E., Stevens K.E. Inhibition of nitric oxide synthase disrupts inhibitory gating of auditory responses in rat hippocampus. J Pharmacol Exp Ther. 287:1998;760-765.
3. Adler LE, Olincy A, Cawthra E, Amass L, Freedman R (in review): Reversal of a deficit in inhibitory gating in cocaine addicts by nicotine administration. Human Psychopharmacol Clin Exp.
4. Adler L.E., Gerhardt G., Franks R., Baker N., Nagamoto H., Drebing C., Freedman R. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatr Res. 31:1990;297-309.
5. Adler L.E., Hoffer L., Nagamoto H., Waldo M.C., Kisley M.A., Griffith J.M. Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology. 10:1994;249-257.
6. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 150:1993;1856-1861.
7. Alder L.E., Pang K., Gerhardt G., Rose G.M. Modulation of the gating of auditory evoked potentials by norepinephrine Pharmacological evidence obtained using a selective neurotoxin . Biol Psychiatry. 24:1988;179-190.
8. Adler L.E., Rose G., Freedman R. Physiological studies of sensory gating in rats Effects of amphetamine, phencyclidine and haloperidol . Biol Psychiatry. 21:1986;787-798.
9. Akpaffiong M.J., Ruiz P. Neuroleptic mallignant syndrome A complication of neuroleptic and cocaine abuse . Psychiatr Q. 62:1991;299-309.
10. Albuquerque E.X., Pereira E.F.R., Castro N.G., Alkondon M., Reinhardt S., Schröder H., Maelick A. Nicotinic receptor function in the mammalian central nervous system. Ann N Y Acad Sci. 757:1995;48-72.
11. Andersen P., Eccles J.C., Loyning Y. Location of postsynaptic inhibitory synapses on hippocampal pyramids. J Neurophysiol. 27:1964;592-607.
12. Angrist B., Sathanthan G., Wilk S., Gershon S. Amphetamine psychosis Behavioral and biochemical aspects . J Psychiatr Res. 11:1974;13-23.
13. Ansis S.F., Smith R.C. Amphetamine abuse and violence. Smith D.E. Amphetamine Use, Misuse and Abuse. 1979;205-217 GK Hall & Co, Boston.
14. Bergles D.E., Doze V.A., Madison D.V., Smith S.J. Excitatory actions of norepinephrine on multiple classes of hippocampal interneurons. J Neurosci. 16:1996;572-585.
15. Berridge C.W., Bolen S.J., Manley M.S., Foote S.L. Modulation of forebrain electroencephalographic activity in halothane-anesthetized rat via actions of noradrenergic beta-receptors within the medial septal region. J Neurosci. 16:1996;7010-7020.
16. Bickford P.C., Wear K.D. Restoration of sensory gating of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats. Brain Res. 705:1995;235-340.
17. Bickford-Wimer P.C., Nagamoto H., Johnson R., Adler L.E., Egan M., Rose G.M., Freedman R. Sensory gating in hippocampal neurons A model system in the rat . Biol Psychiatry. 27:1990;183-192.
18. Boutros N.N., Uretsky N., Bernston G., Bornstein R. Effects of cocaine on sensory inhibition in rats Preliminary data . Biol Psychiatry. 36:1994;242-248.
19. Boutros N.N., Uretsky N., Lui J.J., Millana R.B. Effects of repeated cocaine administration on sensory inhibition in rats Preliminary data . Biol Psychiatry. 41:1997;461-466.
20. Briggs C.A., Anderson D.J., Brioni J.D., Buccafusco J.J., Buckley M.J., Campbell J.E., et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav. 57:1997;231-241.
21. Cook J.D., Ellinwood E.H., Wilson W.P. Auditory habituation at primary cortex as a function of stimulus rate. Exp Neurobiol. 21:1968;167-175.
22. Couturier S., Bertrand D., Matter J., Hernandez M., Bertrand S., Miller N., et al. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-bungarotoxin. Neuron. 5:1990;847-856.
23. Daras M., Kakkouras L., Tuchman A.J., Koppel B.S. Rhabdomyolysis and hyperthermia after cocaine abuse A variant of the neuroleptic malignant syndrome? Acta Neurologica Scandinavica. 9:1995;161-165.
24. 125I-α-bungarotoxin receptor subtypes. Mol Pharmacol. 47:1995;164-171.
25. Fein G., Biggins C., MacKay S. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiatry. 39:1996;955-965.
26. Frazier C.J., Rollins Y.D., Breese C.R., Leonard S., Freedman R., Dunwiddie T.V. Acetylcholine activates an α-bungarotoxin sensitive nicotinic current in rat hippocampal interneurons but not pyramidal cells. J Neurosci. 18:1998;1187-1195.
27. Freedman R., Adler L.E., Bickford P.C., Byerley W., Coon H., Cullum M.C., et al. Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry. 2:1994;179-192.
28. Freedman R., Adler L.E., Gerhardt G.A., Waldo M., Baker N., Rose G.M., et al. Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull. 13:1987;669-678.
29. Freedman R., Adler L.E., Waldo M.C., Myles-Worsley M., Nagamoto H.T., Miller C., et al. Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects Human recordings, computer simulation and an animal model . Arch Gen Psychiatry. 53:1996;1114-1121.
30. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-592.
31. Freedman R., Wetmore C., Strömberg S., Lenoard L., Olson L. α-Bungarotoxin binding to hippocampal interneurons Immunocytochemical characterization and effects on growth factor expression . J Neurosci. 13:1993;1965-1975.
32. Fukushima A. Criminal responsibility in amphetamine psychosis. Jpn J Psychiatry Neurol. 48:1994;1-4.
33. Goff W.R., Williamson P.D., VanGilder J.C., Allison R., Fisher T.C. Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man. Prog Clin Neurophysiol. 7:1980;126-145.
34. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
35. Hall W., Hando J., Darke S., Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 91:1996;81-87.
36. B antagonists diminish the inhibitory gating of auditory response in the rat hippocampus. Neurosci Lett. 190:1995;133-136.
37. Imperato A., Obinu M.C., Demontis V., Gessa G.L. Cocaine releases limbic acetylcholine through endogenous dopamine D1 receptors. Eur J Pharmacol. 229:1992;265-267.
38. Imperato A., Obinu M.C., Gessa G.L. Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur J Pharmacol. 238:1993;377-381.
39. Isaacson J.S., Solis J.M., Nicoll R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron. 10:1993;165-175.
40. Kem W.R. A study of the occurrence of anabaseine in Paranemertes and other nemertines. Toxicon. 9:1971;23-32.
41. Kuczenski R., Segal D.S., Aizenstein M.L. Amphetamine, cocaine, and fencamfamine Relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics . J Neurosci. 11:1991;2703-2712.
42. Li X., Rainnie D.G., McCarley R.W., Greene R.W. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J Neurosci. 18:1998;1904-1912.
43. Luo D., Vincent S.R. NMDA-dependent nitric oxide release in the hippocampus in vivo Interactions with noradrenaline . Neuropharmacol. 33:1994;1345-1350.
44. Luntz-Leybman V., Bickford P.C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
45. Madison D.V., Nicoll R.A. Norepinephrine decreases synaptic inhibition in the rat hippocampus. Brain Res. 442:1988;131-138.
46. McGehee D.S., Heath M.J., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
47. Mendelson J.H., Mello N.K. Management of cocaine abuse and dependence. N Engl J Med. 334:1996;965-972.
48. Miller C.L., Bickford P.C., Luntz-Leybman V., Alder L.E., Gerhardt G.A., Freedman R. Phencyclidine and auditory sensory gating in the hippocampus of the rat. Neuropharmacology. 31:1992;1041-1048.
49. Miller C.L., Freedman R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience. 69:1995;371-381.
50. Mitchell J, Vierkant AD (1991): Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: A comparative study. J Psychol 125:301-310.
51. Pedaranzi P., Storm J.F. Interaction between alpha- and beta-adrenergic receptor agonists modulating the slow Ca(2+)-activated K+ current IAHP in hippocampal neurons. Eur J Neurosci. 8:1996;2098-2110.
52. Reith M.E., Li M.Y., Yan O.S. Extracellular dopamine, norepinephrine and serotonin in the ventral tegmental areas and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake inhibitors. Psychopharmacology. 134:1997;309-317.
53. Segovia G., Porras A., Morea F. Effects of a nitric oxide donor on glutamate and GABA release in straitum and hippocampus of the conscious rat. Neuroreport. 5:1994;1937-1940.
54. Slotnick BM, Leonard CM (1975): A Stereotaxic Atlas of the Albino Mouse Forebrain (HEW Publication No. 75-100). Rockville, MD, Department of Health Education and Welfare.
55. Stevens K.E., Freedman R., Collins A.C., Hall M., Leonard S., Marks M.J., Rose G.M. Genetic correlation of hippocampal auditory evoked response and α-bungarotoxin binding in inbred mouse strains. Neuropsychopharmacology. 15:1996;152-162.
56. Stevens K.E., Fuller L.L., Rose G.M. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating potentials. Brain Res. 555:1991;91-98.
57. Stevens K.E., Kem W.R., Mahnir V., Freedman R. Selective α7 nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology. 136:1998;320-327.
58. Stevens K.E., Meltzer J., Rose G.M. Disruption of sensory gating by the alpha-2 selective noradrenergic antagonist yohimbine. Biol Psychiatry. 33:1993;130-132.
59. Stevens K.E., Meltzer J., Rose G.M. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely-moving rats. Psychopharmacology. 119:1995;163-170.
60. Unnithan S.B., Cutting J.C. The cocaine experience Refuting the concept of a model psychosis? Psychopathology. 25:1992;71-78.
61. 2+. Neuron. 8:1992;353-362.
62. Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., Strang J. Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Dependency. 44:1997;87-94.
63. Yui K., Goto K., Ikemoto S., Ishiguro T. Monoamine neurotransmitter function and spontaneous recurrence of methamphetamine psychosis. Ann N Y Acad Sci. 801:1996;415-429.
64. Zoltewicz J.A., Prokai-Tatrai K., Bloom L.B., Kem W.R. Long range transmission of polar effects in cholinergic 3-arylidene anabaseines. Conformations calculated by molecular modeling. Heterocycles. 35:1993;171-179.